Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome.

Literature DB >> 1535506

Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome.

A La Manna¹, C Polito, A C Foglia, A Di Toro, M R Cafaro, R Del Gado.

Abstract

Vaccination against hepatitis B virus (HBV) was performed in 18 boys (aged 5.7 +/- 2.4 years) suffering from steroid-sensitive nephrotic syndrome (SSNS) and in a control group of 21 healthy boys (aged 5.6 +/- 3.8 years). The percentage of patients who responded to vaccination was significantly lower than the control group 1, 6, 8, 12, 18 and 24 months after the start of vaccination. The titre of antibodies to HBV surface antigen produced by responders at 6 and 24 months was significantly lower in patients than in the control group. Boys with SSNS have an impaired response to HBV vaccination.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1992 PMID： 1535506 DOI： 10.1007/bf00878360

Source DB: PubMed Journal: Pediatr Nephrol ISSN： 0931-041X Impact factor: 3.714

12 in total

1. Genetic prediction of nonresponse to hepatitis B vaccine.

Authors: C A Alper; M S Kruskall; D Marcus-Bagley; D E Craven; A J Katz; S J Brink; J L Dienstag; Z Awdeh; E J Yunis
Journal: N Engl J Med Date: 1989-09-14 Impact factor: 91.245

Review 2. The immune system in minimal change nephrotic syndrome.

Authors: H W Schnaper
Journal: Pediatr Nephrol Date: 1989-01 Impact factor: 3.714

3. Sex distribution of Australia antigen.

Authors: B S Blumberg; A I Sutnick; W T London; L Melartin
Journal: Arch Intern Med Date: 1972-08

4. HlA antigens and steroid responsive nephrotic syndrome of childhood.

Authors: D O'Regan; U O'Callaghan; S Dundon; D J Reen
Journal: Tissue Antigens Date: 1980-08

5. Membranous glomerulonephritis and hepatitis B surface antigen in children.

Authors: C Kleinknecht; M Levy; A Peix; M Broyer; V Courtecuisse
Journal: J Pediatr Date: 1979-12 Impact factor: 4.406

6. Response to hepatitis B vaccine in family members of HBsAg carriers.

Authors: A S Lok; C L Lai; P C Wu; M M Ng
Journal: J Med Virol Date: 1986-05 Impact factor: 2.327

7. Hepatitis B surface antigenaemia and glomerulopathies in children.

Authors: A La Manna; C Polito; R Del Gado; A N Olivieri; R Di Toro
Journal: Acta Paediatr Scand Date: 1985-01

8. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children.

Authors:
Journal: Kidney Int Date: 1978-02 Impact factor: 10.612

Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome.

1. Genetic prediction of nonresponse to hepatitis B vaccine.

Review 2. The immune system in minimal change nephrotic syndrome.

3. Sex distribution of Australia antigen.

4. HlA antigens and steroid responsive nephrotic syndrome of childhood.

5. Membranous glomerulonephritis and hepatitis B surface antigen in children.

6. Response to hepatitis B vaccine in family members of HBsAg carriers.

7. Hepatitis B surface antigenaemia and glomerulopathies in children.

8. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children.

9. HLA extended haplotypes in steroid-sensitive nephrotic syndrome of childhood.

10. Clinical trial of hepatitis B vaccine in the families of HBV carriers.

1. Seroprotection for hepatitis B in children with nephrotic syndrome.

2. Immunization practices in childhood nephrotic syndrome: a survey of North American pediatric nephrologists.

3. Evaluation of Immune and Vaccine Competence in Steroid-Sensitive Nephrotic Syndrome Pediatric Patients.

4. Vaccinations in children on immunosuppressive medications for renal disease.